Ashland Inc.

Valuation Analysis

About the Company

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived r

Ashland Inc. Stock at a Glance

Ashland Inc. (ASH) is currently trading at $64.98 with a market capitalization of $3B. The 52-week range spans from $46.30 to $67.20; the current price is 3.3% below the yearly high. Year-over-year revenue growth stands at +0.6%.

💰 Dividend

Ashland Inc. pays an annual dividend of $1.67 per share, representing a yield of 2.57%. The payout ratio stands at 40%.

📊 Analyst Rating

11 analysts rate Ashland Inc. (ASH) on consensus: Buy. The average price target is $67.27, implying +3.53% from the current price. Analyst price targets range from $50.00 to $90.00.

Ashland Inc.: The Investment Case in Detail

Ashland Inc. (ASH) operates in the Basic Materials — specifically Specialty Chemicals — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bear Case

Revenue growth has slowed to just 0.6%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Short interest sits at 13.53% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valuation in Context

The PEG ratio at 1.23 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (13.53%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Ashland Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.